YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Pharmacogenetics of Cannabinoid Response
Early Phase 1
Completed
- Conditions
- COMT Gene Polymorphism
- Interventions
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 72
- Registration Number
- NCT00678730
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).
Not Applicable
Withdrawn
- Conditions
- Drug Dependence
- Interventions
- Behavioral: Primary Care CounselingBehavioral: Cognitive-behavioral psychotherapy
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- Yale University
- Registration Number
- NCT00675532
- Locations
- 🇺🇸
Yale New Haven Hospital Primary Care Center, New Haven, Connecticut, United States
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
Phase 2
Completed
- Conditions
- Gastroesophageal CancerGastric Cancer
- Interventions
- Drug: FOLFOX
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Yale University
- Target Recruit Count
- 39
- Registration Number
- NCT00673673
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸Medical Oncology & Hematology PC, Hamden, Connecticut, United States
Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium Metabolism
Phase 1
Completed
- Conditions
- Osteoporosis
- Interventions
- Other: Low protein diet
- First Posted Date
- 2008-05-05
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- Yale University
- Target Recruit Count
- 11
- Registration Number
- NCT00671944
- Locations
- 🇺🇸
Yale New Haven Hospital Research Unit, New Haven, Connecticut, United States
Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance
Phase 4
Completed
- Conditions
- Pediatric ObesityInsulin ResistanceHyperinsulinemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-04-28
- Last Posted Date
- 2009-02-18
- Lead Sponsor
- Yale University
- Target Recruit Count
- 28
- Registration Number
- NCT00667498
- Locations
- 🇺🇸
Yale Center for Clinical Investigation (YCCI), New Haven, Connecticut, United States
Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
Completed
- Conditions
- IschemiaMyocardial InfarctionIschemic Heart Disease
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 1
- Registration Number
- NCT00661323
- Locations
- 🇺🇸
Yale University/Magnetic Resonance Research Center (MR-TAC)/Yale New Haven Hospital, New Haven, Connecticut, United States
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Yale University
- Target Recruit Count
- 25
- Registration Number
- NCT00660192
- Locations
- 🇺🇸
Yale Physician's Building, 800 Howard Ave, lower level,, New Haven, Connecticut, United States
Impact of Oral Contraceptives on GABA and Neurosteroids
Terminated
- Conditions
- Healthy
- Interventions
- Other: oral contraceptive pill (OCP; OCPs)
- First Posted Date
- 2008-04-11
- Last Posted Date
- 2009-08-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT00656318
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type I
- Interventions
- Drug: Insulin analogs (Lispro and Aspart)Drug: Insulin analogs (Aspart and Detemir)Drug: Insulin analogs (Lispro and Glargine)
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Yale University
- Target Recruit Count
- 36
- Registration Number
- NCT00652288
Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)
Completed
- Conditions
- Infection, Mycobacterium Avium-Intracellulare
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 1
- Registration Number
- NCT00652067